Serine/threonine-protein kinase 26

BE0004109ProteinHumansSTK26

Serine/threonine-protein kinase that acts as a mediator of cell growth (PubMed:11641781, PubMed:17360971). It is acted on by 2 drugs in DrugBank.

Gene name
STK26
UniProtKB entry
Q9P289Swiss-Prot
Cellular location
Cytoplasm
Residues / weight
416 residues · 46,528 Da
Also known as
2.7.11.1 · Mammalian STE20-like protein kinase 4 · MASK · MST-4 · MST3 and SOK1-related kinase

Resolves to

Protein
UniProtQ9P289UniProt nameSTK26_HUMAN
Gene
HGNCHGNC:18174NCBI Gene51765GenBank13702675GeneCardsSTK26
Pharmacology
KEGGhsa:51765
Structure
PDB3GGFPDB3W8IPDB4FZA
Drugs

What you can answer from here — as of September 03, 2024

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
17GO termsFunction, process and component, as structured annotations
Sign in
2Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
24+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Serine/threonine-protein kinase 26, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In